CN106074553A - 含有西格列汀和二甲双胍的药物组合物 - Google Patents
含有西格列汀和二甲双胍的药物组合物 Download PDFInfo
- Publication number
- CN106074553A CN106074553A CN201610421011.6A CN201610421011A CN106074553A CN 106074553 A CN106074553 A CN 106074553A CN 201610421011 A CN201610421011 A CN 201610421011A CN 106074553 A CN106074553 A CN 106074553A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- metformin
- sitagliptin
- label
- sealing coat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
隔离层材料及其质量比 | |
实施例4 | 滑石粉:羟丙甲纤维素E3=2:1 |
实施例5 | 滑石粉:羟丙甲纤维素E3=1:2 |
实施例6 | 羟丙甲纤维素E3 |
实施例7 | 滑石粉:羟丙基纤维素=1:1 |
实施例8 | 滑石粉:羟丙基纤维素=2:1 |
实施例9 | 滑石粉:羟丙基纤维素=1:2 |
实施例10 | 羟丙基纤维素 |
实施例11 | 滑石粉:聚乙烯醇=1:1 |
实施例12 | 滑石粉:聚乙烯醇=2:1 |
实施例13 | 滑石粉:聚乙烯醇=1:2 |
实施例14 | 聚乙烯醇 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610421011.6A CN106074553B (zh) | 2016-06-13 | 2016-06-13 | 含有西格列汀和二甲双胍的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610421011.6A CN106074553B (zh) | 2016-06-13 | 2016-06-13 | 含有西格列汀和二甲双胍的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106074553A true CN106074553A (zh) | 2016-11-09 |
CN106074553B CN106074553B (zh) | 2019-02-22 |
Family
ID=57846485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610421011.6A Active CN106074553B (zh) | 2016-06-13 | 2016-06-13 | 含有西格列汀和二甲双胍的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106074553B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022035400A1 (en) * | 2020-08-11 | 2022-02-17 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A tablet formulation comprising sitagliptin and metformi̇n |
CN115245495A (zh) * | 2022-09-21 | 2022-10-28 | 北京惠之衡生物科技有限公司 | 一种西格列汀二甲双胍片及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101365432A (zh) * | 2005-12-16 | 2009-02-11 | 默克公司 | 二肽基肽酶-4抑制剂与二甲双胍的组合的药物组合物 |
CN102626396A (zh) * | 2012-04-28 | 2012-08-08 | 海南华益泰康药业有限公司 | 一种美托洛尔缓释片剂及其制备方法 |
CN103655570A (zh) * | 2013-12-11 | 2014-03-26 | 深圳翰宇药业股份有限公司 | 西格列汀与二甲双胍复方缓释制剂及其制备方法 |
CN104324033A (zh) * | 2014-11-20 | 2015-02-04 | 哈尔滨圣吉药业股份有限公司 | 一种西格列汀二甲双胍缓释片及其制备方法 |
CN105534979A (zh) * | 2016-03-04 | 2016-05-04 | 中国药科大学 | 一种埃索美拉唑镁肠溶片剂及其制备方法 |
-
2016
- 2016-06-13 CN CN201610421011.6A patent/CN106074553B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101365432A (zh) * | 2005-12-16 | 2009-02-11 | 默克公司 | 二肽基肽酶-4抑制剂与二甲双胍的组合的药物组合物 |
CN102626396A (zh) * | 2012-04-28 | 2012-08-08 | 海南华益泰康药业有限公司 | 一种美托洛尔缓释片剂及其制备方法 |
CN103655570A (zh) * | 2013-12-11 | 2014-03-26 | 深圳翰宇药业股份有限公司 | 西格列汀与二甲双胍复方缓释制剂及其制备方法 |
CN104324033A (zh) * | 2014-11-20 | 2015-02-04 | 哈尔滨圣吉药业股份有限公司 | 一种西格列汀二甲双胍缓释片及其制备方法 |
CN105534979A (zh) * | 2016-03-04 | 2016-05-04 | 中国药科大学 | 一种埃索美拉唑镁肠溶片剂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022035400A1 (en) * | 2020-08-11 | 2022-02-17 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A tablet formulation comprising sitagliptin and metformi̇n |
CN115245495A (zh) * | 2022-09-21 | 2022-10-28 | 北京惠之衡生物科技有限公司 | 一种西格列汀二甲双胍片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106074553B (zh) | 2019-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101500568A (zh) | 匹莫范色林的药物制剂 | |
SG193338A1 (en) | Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor | |
CN102861106B (zh) | 一种复方氨酚烷胺微丸的制备方法 | |
CN106924208A (zh) | 一种复方达格列净二甲双胍缓释片及其制备方法 | |
US20230190732A1 (en) | Pharmaceutical composition containing nitroxoline prodrug, and preparation method and application therefor | |
CN103479592B (zh) | 一种盐酸二甲双胍缓释片及其制备方法 | |
CN103768063B (zh) | 一种盐酸莫西沙星药物组合物及其制备方法 | |
EP3216450B1 (en) | Pharmaceutical preparation comprising cyclin inhibitor and preparation method thereof | |
CN111407730A (zh) | 一种含有利格列汀的药物组合物 | |
CN106176653A (zh) | 一种西格列汀的药物组合物 | |
CN106074553A (zh) | 含有西格列汀和二甲双胍的药物组合物 | |
KR20200078353A (ko) | 엠파글리플로진 및 시타글립틴을 포함하는 약학적 조성물 | |
CN104873473A (zh) | 一种氯化钾缓释片及其制备方法 | |
CN105434377A (zh) | 美索舒利片剂及其制备方法 | |
CN105878256A (zh) | 含有盐酸二甲双胍和格列美脲的控释制剂及其制备方法 | |
CN105395506B (zh) | 一种盐酸可乐定缓释片 | |
JP2022544167A (ja) | ニトロキソリンを含む医薬組成物、ニトロキソリン経口固形錠剤、その調製方法、及びその使用 | |
CN103127108B (zh) | 替米沙坦氨氯地平片及其制备方法和用途 | |
RU2533560C2 (ru) | Фармацевтическая композиция для лечения диабета 2 типа | |
US8476272B2 (en) | Pharmaceutical composition for treatment of type 2 diabetes | |
CN106265557A (zh) | 含有替格瑞洛的药物组合物 | |
CN105030717A (zh) | 一种盐酸莫西沙星薄膜衣片及其制备方法 | |
JP2023551056A (ja) | 固体分散体、医薬製剤、その製造方法及び応用 | |
CN101919851B (zh) | 治疗哺乳动物包括人2型糖尿病的药物组合物 | |
CN102370629B (zh) | 恩替卡韦液体胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210303 Address after: Hangzhou City, Zhejiang province Gongshu District 310011 Moganshan Road No. 866 Patentee after: HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL Co.,Ltd. Address before: 310012 c910, Xihu international science and technology building, 391 Wener Road, Hangzhou City, Zhejiang Province Patentee before: HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161109 Assignee: HUADONG MEDICINE Co.,Ltd. Assignor: HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2023330000031 Denomination of invention: Pharmaceutical composition containing Sigliptin and Metformin Granted publication date: 20190222 License type: Common License Record date: 20230131 |